Funding application to the “Helse Nords forskningsmidler” for the project “Branching out – Development of radiocopper (Cu-64/Cu-67) radiopharmaceuticals for precision medicine theranostics in glioblastoma vascularization” has been granted. Project leader: Mathias Kranz. Congratulations!
